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Background: Our previous studies have indicated that both lumbar spinal cord-infiltrating CD4+ T cells and
microglial CD40 contribute to the maintenance of mechanical hypersensitivity in a murine model of neuropathic
pain spinal nerve L5 transection (L5Tx). To further delineate the CD4 and CD40-mediated mechanisms involved in
the development of L5Tx-induced neuropathic pain behaviors, we examined the lumbar spinal cord mononuclear
cells of wild type (WT) BALB/c, BALB/c-CD4 knockout (KO), and BALB/c-CD40 KO mice via flow cytometry.
Results: In WT mice, L5Tx induced significant but transient (at day 3 and/or day 7) increases of the total numbers
of mononuclear cells, microglial cells (CD45loCD11b+), and infiltrating leukocytes (CD45hi) in the ipsilateral side of
the spinal cord. In CD4 KO mice, significant elevation of microglia was detected only on day 7 post-L5Tx, while no
significant increase in infiltrating leukocytes post-L5Tx was observed. CD40 KO mice did not exhibit any of the
changes observed in WT mice. Furthermore, neutralizing CD40 antibody treatment indicated an early involvement
of CD40 signaling in the development of L5Tx-induced mechanical hypersensitivity.
Conclusions: Altogether, data indicate that both CD4 and CD40 play a role in L5Tx-induced leukocyte infiltration
into the lumbar spinal cord but have differential contributions to spinal cord microglial activation following
peripheral nerve injury.
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Neuropathic pain, defined as pain caused by a lesion or
disease of the somatosensory system [1], is still largely
treated suboptimally due to the limited understanding of
the development and progression of neuropathic pain.
Several research groups have demonstrated that central
nervous system (CNS) glial cell activation and neuro-
inflammation are critical in the induction and mainten-
ance of neuropathic pain in part through central
sensitization [2-4].
Our laboratory has been investigating the underlying
neuroimmune mechanisms in neuropathic pain using a* Correspondence: lcao@une.edu
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reproduction in any medium, provided the ormurine model, spinal nerve L5 transection (L5Tx).
Leukocyte infiltration into the affected nerve has been
reported in human patients suffering neuropathic pain
[5]. We are particularly interested in the roles of spinal
cord infiltrating leukocytes and potential interaction be-
tween the infiltrating leukocytes and spinal cord resident
glial cells. Previously, we have shown that L5Tx induced
a significant but transient increase of CD4+ T lympho-
cyte infiltration into the lumbar spinal cord that peaked
at day 7 post-L5Tx, and CD4 knockout (KO) mice dis-
played reduced mechanical hypersensitivity starting
around 7 days post-L5Tx [6]. As recently reviewed by
Grace et al. [7], pre-clinical studies have provided evi-
dence suggesting the involvement of multi-level interac-
tions among infiltrating leukocytes, particularly CD4+ T
lymphocytes, microglia, astrocytes, and neurons along. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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opment of neuropathic pain. Both localized break down
of the blood-spinal cord barrier following nerve injury
[8] and production of chemokines within the spinal cord
[9-11] are thought to be critical in facilitating leukocyte
infiltration.
To further investigate the role of infiltrating CD4+ T
lymphocytes in the maintenance of L5Tx-induced behav-
ioral hypersensitivity, we proposed the potential involve-
ment of the interaction between infiltrating CD4+ T
lymphocytes and microglia via microglia-expressing
CD40. CD40, a 48 kD cell surface tumor necrosis factor
(TNF) family receptor, has been found to be upregulated
in microglia upon activation both in vitro and in vivo
[12-16]. CD40 has also been linked to the pathogenesis
of various CNS diseases including multiple sclerosis and
Alzheimer’s disease [17-19]. Our studies showed that
both CD40 KO mice or bone marrow chimeric mice that
have little CD40 expression in the CNS displayedFigure 1 Flow cytometric analysis of lumbar spinal cord mononuclear
ipsilateral or contralateral side of lumbar spinal cords from 3–4 mice) were
examined with an Accuri C6 flow cytometer and analyzed with FlowJo. Fo
microglia (CD45loCD11b+) (B) and infiltrating leukocytes (CD45hi) (C) were i
each of these populations within the total cells was recorded. The total nu
calculated based on the recorded percentages, the total mononuclear cells
Representative plots shown here are from a “WT day 3 L5Tx ipsilateral” spinsignificantly reduced L5Tx-induced mechanical hyper-
sensitivity during the maintenance phase starting at 3–5
days post-L5Tx, suggesting the role of microglial CD40
in the development of L5Tx-induced mechanical hyper-
sensitivity [16].
Our previous data indicate differential reductions of
L5Tx-induced mechanical hypersensitivity when com-
paring CD4 KO and CD40 KO mice, that is CD40 KO
mice displayed greater and earlier reduction of mech-
anical hypersensitivity [6,16]. We suspect the co-
existence of distinct CD4- and CD40- mediated
mechanisms in the development of neuropathic pain.
Here, we further delineate these underlying mechan-
isms by examining lumbar spinal cord mononuclear
cells collected from wide type (WT), CD4 KO and
CD40 KO mice via flow cytometry. Follow-up studies
with neutralizing CD40 antibody were performed to
identify the specific timing of CD40 signaling
involvement.cells. Total mononuclear cells collected from each sample (pooled
labeled with mAbs against CD11b and CD45. All samples were
r each sample, total cell population was first identified (A), and then
dentified within the gated total cell population. The percentage of
mber of microglia and infiltrating leukocytes per spinal cord were
collected, and the number of mice used in each sample.
al cord mononuclear cell sample.
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Flow cytometric analysis of lumbar spinal cord
mononuclear cells
Adult male and female WT, CD4 KO and CD40 KO
mice were subjected to either L5Tx or sham surgery. At
selected times, days 0 (naïve groups), 1, 3, 7, and 14
post-surgery, mice (for each genotype, 3–4 mice per
treatment group) were euthanized and lumbar spinal
cord samples (separated into ipsilateral and contralateral
sides) were harvested and pooled to obtain mononuclear
cells as described in the Materials and Methods (illu-
strated in Figure 1). Total mononuclear cells harvested
from lumbar spinal cord are known to contain both in-
filtrating leukocytes and resident microglia. In WT mice,
L5Tx induced a significant but transient increase of the
total number of lumbar spinal cord mononuclear cells in
the ipsilateral side of the spinal cord, which peaked be-
tween days 3 and 7 post-L5Tx (Figure 2A, two-way
ANOVA, ptreatment = 0.003, ptime = 0.004, and ptreatment x
time = 0.920). Although similar trends in the changes of
the total lumbar spinal cord mononuclear cells were
observed in both CD4 KO and CD40 KO mice, no sta-
tistically significant differences were detected in either
type of KO mice (Figures 2B and C, two-way ANOVA,
in B, ptreatment = 0.304, ptime = 0.392, and ptreatment x time
= 0.968; in C, ptreatment = 0.131, ptime = 0.114, and ptreat-
ment x time = 0.962). Further, total mononuclear cells were
analyzed based on their microglial (CD45loCD11b+) and
infiltrating leukocyte (CD45hi) content (as illustrated in
Figure 1). As expected, WT mice showed a significant
increase of microglial number in the ipsilateral side on
both days 3 and 7 post-L5Tx (Figure 3A, two-way
ANOVA, ptreatment = 0.007, ptime < 0.001, and ptreatment x
time = 0.460). Interestingly, significant increase ofFigure 2 Numbers of total mononuclear cells in lumbar spinal cord fo
CD40 KO mice were subjected to sham or L5Tx surgery. Lumbar spinal cor
were collected at indicated times post-surgery. The temporal changes of th
(A, n = 5–8), CD4 KO (B, n = 4) and CD40 KO (C, n = 4) mice are shown he
basal level genotypic differences among naïve mice and no significant diffe
performed. * indicates significant differences between the indicated group
differences between the indicated group and the corresponding Day 0 gro
shown within the graph. “Tx” = L5Tx, “Sh” = sham operation, “ipsi” = ipsilat
and “contra” = right.microglial number was only observed at day 7 post-
L5Tx in CD4 KO mice (Figure 3B, two-way ANOVA,
ptreatment = 0.091, ptime < 0.001, and ptreatment x time =
0.077), and no significant microglial increase was
observed in CD40 KO mice at any time after L5Tx
(Figure 3C, two-way ANOVA, ptreatment = 0.828, ptime =
0.348, and ptreatment x time = 0.955). Consistent with our
previous report, significantly increased numbers of infil-
trating leukocytes were detected in the ipsilateral side of
lumbar spinal cord in WT mice at day 7 post-L5Tx
(Figure 4A, two-way ANOVA, ptreatment = 0.422,
ptime < 0.001, and ptreatment x time = 0.839). However, in
either CD4 KO or CD40 KO mice, no significant
increases of infiltrating leukocytes were observed within
any treatment groups or sides relative to the surgery
(Figure 4B and C, two-way ANOVA, in B, ptreatment =
0.824, ptime = 0.015, and ptreatment x time = 0.823; in C,
ptreatment = 0.972, ptime < 0.001, and ptreatment x time =
0.988; for both B and C, no differences related to factor
“time” were further identified within each surgery/side
group with the SNK post-hoc test). In addition, there
were no differences in all parameters measured among
naïve mice at the basal levels across all three genotypes
(Figures 2, 3 and 4, one-way ANOVA, p > 0.05).
Effects of anti-CD40 treatment
Our data from lumbar mononuclear cell analyses suggest
that spinal cord CD40 might play a more important role
compared to CD4 in the development of peripheral
nerve injury-induced behavioral hypersensitivity in part
through the inhibition of microglial activation and the
infiltration of peripheral leukocytes into the spinal cord.
We next examined the time when CD40 signaling is crit-
ical in the development of L5Tx-induced behavioralllowing L5Tx in WT, CD4KO, and CD40KO mice. WT, CD4 KO, and
d mononuclear cells from separate groups of mice of each genotype
e numbers of total lumbar spinal cord mononuclear cells in WT
re (mean ± SEM). One-way ANOVA was performed to examine the
rences were found. Two-way ANOVA for data sets in each graph were
and all other groups at the same time point. # indicates significant
up. An additional significant result from statistical comparison is also
eral side, and “contra” = contralateral side. For naïve mice, “ipsi” = left
Figure 3 Numbers of microglia (CD45loCD11b+) in lumbar spinal cord following L5Tx in WT, CD4KO, and CD40KO mice. Total
mononuclear cells collected as described in Figure 2 were analyzed for their microglial content. The temporal changes of the numbers of lumbar
spinal cord microglia in WT (A, n = 5–8), CD4 KO (B, n = 4) and CD40 KO (C, n = 4) mice are shown here (mean ± SEM). One-way ANOVA was
performed to examine the basal level genotypic differences among naïve mice and no significant differences were found. Two-way ANOVA for
data sets in each graph were performed. * indicates significant differences between the indicated group and all other groups at the same time
point. # indicates significant differences between the indicated group and all other groups within the same treatment group (including the
corresponding Day 0 group). #1 indicates significant differences between the indicated group and days 0, 1 and 14 groups within the same
treatment group. An additional significant result from statistical comparison is also shown within the graph. “Tx” = L5Tx, “Sh” = sham operation,
“ipsi” = ipsilateral side, and “contra” = contralateral side. For naïve mice, “ipsi” = left and “contra” = right.
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nistered daily to WT mice either from day −1 to day 7
or from day 6 to day 14 via intrathecal (i.t.) injection
(L5Tx was performed on day 0). Saline-injected mice
were used as controls. As expected, mice who received
saline (regardless of time period) displayed significant
mechanical hypersensitivity after L5Tx that was main-
tained up to day 21 post-L5Tx (Figure 5) and is similar
to what we have observed in non-treated WT mice fol-
lowing L5Tx surgery [6,16]. Further, when administered
from day −1 to day 7, both doses of anti-CD40, 1 μg/day
and 5 μg/day significantly reduced L5Tx-induced mech-
anical hypersensitivity (Figure 5A, two-way RM
ANOVA, ptreatment = 0.0162, ptime < 0.0001, and ptreatment
x time = 0.0096). However, this effect on mechanicalFigure 4 Numbers of infiltrating leukocytes (CD45hi) in lumbar spinal
mononuclear cells collected as described in Figure 2 were analyzed for the
numbers of lumbar spinal cord infiltrating leukocytes in WT (A, n = 5–8), CD
SEM). One-way ANOVA was performed to examine the basal level genotyp
found. Two-way ANOVA for data sets in each graph were performed. # ind
groups within the same treatment group (including the corresponding Da
also shown within the graph. “Tx” = L5Tx, “Sh” = sham operation, “ipsi” = ip
left and “contra” = right.hypersensitivity was gradually diminished following the
last treatment of anti-CD40 and by day 21 post-L5Tx
there was no difference in mechanical sensitivity among
all treatment groups (Figure 5A). Interestingly, when
administered from day 6 to day 14, anti-CD40 did not
exert any effect on L5Tx-induced mechanical hypersen-
sitivity (Figure 5B, two-way RM ANOVA, ptreatment =
0.132, ptime < 0.001, and ptreatment x time = 0.782).
Discussion
Previously, we have shown that both infiltrating CD4+ T
lymphocytes and spinal cord microglial CD40 are
involved in the maintenance of L5Tx-induced mechan-
ical hypersensitivity. To further identify the CD4- and
CD40- mediated mechanisms, for the first time, wecord following L5Tx in WT, CD4KO, and CD40KO mice. Total
ir content of infiltrating leukocytes. The temporal changes of the
4 KO (B, n = 4) and CD40 KO (C, n = 4) mice are shown here (mean ±
ic differences among naïve mice and no significant differences were
icates significant differences between the indicated group and all other
y 0 group). An additional significant result from statistical comparison is
silateral side, and “contra” = contralateral side. For naïve mice, “ipsi” =
Figure 5 Mechanical hypersensitivity of WT mice treated with anti-CD40. WT mice were subjected to L5Tx. Neutralizing CD40 antibody was
i.t. administered to WT mice daily either from day −1 to day 7 (A) or from day 6 to day 14 (B). Mechanical sensitivity of each mouse was tested
before L5Tx and repeatedly after L5Tx using a series of von Frey filaments via the up-down method. All data are presented as mean ± SEM
(n = 6). Two-way RM ANOVA was performed for data sets within each graph. * indicates the significant differences between the indicated group
and the saline treated group within the same time point. In addition, within each treatment group, p < 0.05 between any time point post-L5Tx
and both day 0 and day −1 time points (not indicated in the graph).
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WT, CD4 KO and CD40 KO mice via flow cytometry. It
is known that both microglia and infiltrating leukocytes
are important components within lumbar spinal cord
mononuclear cells, thus we focused our investigation on
these two populations.
First, our data showed that the total numbers of
mononuclear cells collected from both CD4 KO and
CD40 KO mice are comparable to that collected from
WT mice at all selected time points post-surgery. Fur-
thermore, for all parameters evaluated, there are no sig-
nificant genotypic differences detected in naïve mice.
These observations indicate that depletion of either CD4
or CD40 does not result in a reduction of total mono-
nuclear cells within the lumbar spinal cord prior to any
treatment, and differences detected among mice with
different genotypes are most likely not due to the
reduced availability of the specific cell populations that
were analyzed.
In CD4 KO mice (that are known to have no CD4+ T
cells), unlike in WT mice, no significant leukocyte infil-
tration was observed at day 7 post-L5Tx. This is consis-
tent with our previous finding that CD4+ T cells are the
dominant population detected at 7 days post-L5Tx in
the lumbar spinal cord. Unexpectedly, our data indicate
that a lack of CD4+ T cells can affect L5Tx-induced early
increase of lumbar spinal cord microglial content. In-
crease in the total number of microglia is one of many
signs of microglial activation during the development of
neuropathic pain [2-4]. Although the peak time for
detecting infiltrating CD4+ T cells is at 7 days post-L5Tx
[16], it is possible that early-stage infiltrating CD4+ T
cells play a critical role in microglial activation. In other
words, lumbar spinal cord infiltrating CD4+ T cells po-
tentially contribute to the maintenance of L5Tx-induced
neuropathic pain in part through enhancing spinal cordmicroglial activation during the transition from the initi-
ation phase to the maintenance phase of neuropathic
pain behavioral development post-L5Tx.
In CD40 KO mice, neither increased leukocyte infiltra-
tion nor increased microglial number were observed fol-
lowing L5Tx as that in WT mice, indicating that CD40
is critical in both leukocyte infiltration and microglial ac-
tivation post-L5Tx. Previously, we have demonstrated
the role of CD40+ microglia in the maintenance of
L5Tx-induced neuropathic pain behavior [16]. It has
been shown that CD40-mediated, activated microglia are
capable of releasing several chemokines, including CCL2
(also known as Monocyte chemoattractant protein-1
(MCP-1)), CCL5 (also known as regulated and normal
T cell expressed and secreted (RANTES)), and CXCL10
(also known as interferon gamma-induced protein 10
(IP-10)) [20]. Together, we propose that depletion of
CD40 significantly reduces the ability of spinal cord
microglia to become fully activated, thus leading to a
decreased production of various chemoattractant cyto-
kines by activated microglia and subsequently reduced
infiltration of peripheral leukocytes. Further, it is known
that CD40 stimulation can lead to increased expression
of certain adhesion molecules on both leukocytes and
endothelial cells [21,22]. Elevated expression of adhesion
molecules has been observed in activated microglia
[13,23,24]. Thus, depletion of CD40 may limit an injury-
induced increase of the total number of microglia at the
injury site by reducing the migration of microglia to-
wards the injury site. Reduced expression of adhesion
molecules by endothelial cells could also contribute to
the reduced infiltration of peripheral leukocytes. Never-
theless, whether the CD40 depletion-related low level of
microglial activation is due to the lack of active CD40
signaling during the development of neuropathic pain or
CD40 depletion-induced developmental defects of
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did notice somewhat larger variations in all parameters
we measured within CD40 KO mice, particularly
changes between day 1 and day 7 post-surgery. Although
it seems that surgery induced a greater increase of the
total microglial number (particularly at day 1) in CD40
KO mice than those in WT and CD4 KO mice, no statis-
tical significance was found. Future studies aiming to in-
vestigate the properties of microglia in CD40 KO mice
in more detail may help to explain this observation.
Given the critical role of CD40, to further identify the
times when active CD40 signaling is necessary in the de-
velopment of neuropathic pain behavior post-L5Tx, we
performed a series of studies with CD40-neutralizing
antibody in WT mice. Although CD40 contributes
mostly to the maintenance of L5Tx-induced neuropathic
pain behavior [16], our data suggest that both early (dur-
ing the initiation phase) and continued activation of
CD40 signaling are essential in maintaining neuropathic
pain behavior. In the current study, even with the high-
est dose of anti-CD40, we were unable to reverse L5Tx-
induced mechanical hypersensitivity to a comparable
level that has been reported in CD40 KO mice post-
L5Tx by us previously [16]. This could be due to either
the limited blocking ability of the neutralizing antibody
used or that CD40-depletion related intrinsic develop-
mental defects of microglia also contributes to the re-
duction of L5Tx-induced mechanical hypersensitivity in
CD40 KO mice. As discussed above, future studies will
be carried out to further characterize the microglial
population from CD40 KO mice.
Conclusions
Altogether, our data indicate that both CD4 and CD40
play a role in L5Tx-induced leukocyte infiltration into
the lumbar spinal cord but have differential contribu-
tions to spinal cord microglial activation following pe-
ripheral nerve injury. Studies with CD40 neutralizing
Ab suggest that CD40 is required early on in order to




Both male and female WT BALB/c mice (7–8 weeks
old) were purchased from the National Cancer Institute
(NCI, Frederick, MD) and were allowed to habituate to
the institutional animal facility for at least one week be-
fore experimental use (8–9 weeks old). As previously
described in detail [6,16], breeding pairs for BALB/c-
CD4 KO mice and BALB/c-CD40 KO mice were origin-
ally obtained from Dr. William T. Lee of the Wadsworth
Center, New York State Department of Health and the
Jackson Laboratory (Bar Harbor, ME) respectively, andcurrently maintained at the University of New England
(UNE) animal facility by breeding respective homozy-
gous KO mice. All mice were group-housed (3–4 per
cage) with food and water ad libitum and maintained on
a 12-h light/dark cycle. Initially, experiments with just
male or female WT mice were conducted. Since no sig-
nificant differences in all parameters measured were
observed and production of just male or female KO
mice were limited, mixed male and female populations
were used in all later experiments (including experi-
ments with both WT and KO mice). The overall ratio
between male and female mice within individual geno-
types used in each set of experiments was around 1:1.
The Institutional Animal Care and Use Committee
(IACUC) at UNE approved all experimental procedures
used in this study.
L5Tx and spinal cord sample collection
WT, CD4 KO and CD40 KO mice were randomly
selected into either sham or L5Tx groups. L5Tx and
sham surgeries were conducted following previously
published procedures [6]. We have shown that L5Tx-
induced mechanical hypersensitivity can be observed up
to 21 days post-surgery in WT BALB/c mice, while both
CD4 KO and CD40 KO mice displayed reduced L5Tx-
induced hypersensitivity with greater and earlier reduc-
tion detected in CD40 KO mice [6,16]. Our data also
indicated that the peak time for detecting lumbar spinal
cord infiltration of CD4+ T cells is day 7 post-L5Tx,
while the optimal time for detecting lumbar spinal cord
microglial activation is day 3–7 post-L5Tx. Thus, for
each genotype, lumbar spinal cord samples (separated
into ipsilateral and contralateral sides according to the
side of injury) were collected at days 0 (naïve), 1, 3, 7
and 14 post-surgery following transcardiac perfusion as
described previously [6,16]. Separate groups of mice
were used at each time point. Since pooled samples were
needed for flow cytometric analyses (see below Flow
cytometry), each set of experiments with 3–4 mice
per group produced only one data point for each group
(n = 1). In order to perform statistical analyses, the same
experiment was repeated several times (each time with
3–4 mice per group), i.e. the “n” shown in the results
and figures indicates the number of repeated experi-
ments, not individual animals.
Flow cytometry
As previously described, mononuclear cells were pre-
pared from pooled (3–4 mice) mouse lumbar spinal cord
tissue (separated into ipsilateral and contralateral sides
according to the side of nerve injury) using a discontinu-
ous Percoll (Amersham, Piscataway, NJ) gradient and
labeled for flow cytometric analysis [6]. Briefly, spinal
cord tissue was first homogenized and filtered through a
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Total cell suspension was then separated with 40% /70%
Percoll gradients and mononuclear cells were collected
from the layer that was below 40% and above 70% gradi-
ent. After washing with phosphate buffered saline, the
total mononuclear cell number was determined using a
hemacytometer with trypan blue (Sigma, St Louis, MO)
before staining. All monoclonal antibodies (mAbs) were
obtained from either BD Biosciences or eBioscience (San
Diego, CA). Cell surface Fc receptors were blocked by
anti-mouse-CD16/CD32 (clone 2.4G2) and then stained
with fluorescent-labeled mAbs: APC-anti-mouse CD45
(clone 30-F11) and PE-anti-mouse CD11b (clone M1/70).
All events from each sample were collected using an
Accuri C6 flow cytometer (BD Biosciences - Accuri, Ann
Arbor, MI) and further analyzed with FlowJo software
(Tree Star, Inc., Ashland, OR). As previously published
[6,16], mononuclear cells harvested from lumbar spinal
cord are known to contain both infiltrating leukocytes and
resident microglia. It has been established that the
pan-leukocyte marker CD45 can be used to distinguish
infiltrating leukocytes from the CNS resident, monocyte-
derived microglia by flow cytometry, with CD45hi repre-
senting infiltrating leukocytes and CD45lo indicating
microglia [25,26]. It is known that the majority of micro-
glia express CD11b regardless of their activation status,
thus it is generally accepted that cells expressing
CD45loCD11b+ are identified as microglia [27,28]. As
illustrated in Figure 1, for each sample, following the iden-
tification of total cell population within the SSC vs. FSC
plot, CD45loCD11b+ cells were identified as microglia and
CD45hi cells were identified as infiltrating leukocytes
(Figure 1). Non-stained cells were included in each run as
controls. Data were reported as total number/lumbar
spinal cord (ipsilateral or contralateral side).
Anti-CD40 treatment and mechanical sensitivity test
WT BALB/c mice were randomly divided into two
groups corresponding to the two treatment regimens: 1)
treatment was administered daily from day −1 to day 7
post-L5Tx; 2) treatment was administered daily from day
6 to day 14 post-L5Tx. Within each regimen, three sub-
groups were included: saline control (5μl per injection),
anti-CD40 at 1 μg/5μl per injection, and anti-CD40 at 5
μg/5μl per injection. All mice were subjected to L5Tx at
day 0. Neutralizing CD40 antibody was obtained from
eBioscience (clone HM40-3) and diluted with sterile sa-
line to a final concentration at either 1 mg/ml (for 5 μg
per injection) or 0.2 mg/ml (for 1 μg per injection). Sa-
line or anti-CD40 at either dose was administered to
each individual mouse through intrathecal (i.t.) injection
as previously described [29].
All mice were tested for their mechanical sensitivity
using a series of von Frey filaments (Stoelting, WoodDale, IL) as previously described [6,16,30]. Baseline tests
were performed before L5Tx and follow-up tests were
performed at days 1, 3, 5, 7, 10, 14, 17 and 21 post-
L5Tx. The person performing the behavioral test was
blinded to the treatment groups of individual animals.
Statistical Analysis
All data were graphed with SigmaPlot 10.0 (Systat Soft-
ware, Inc. San Jose, CA) and analyzed using SigmaStat
3.5 (Systat Software, Inc. San Jose, CA). One-way ana-
lyses of variance (ANOVA) were used to examine the
basal level genotypic differences among naïve mice.
Two-way ANOVA (for comparing the results obtained
from flow cytometric analyses for each genotype of
mice) or two-way repeated measures (RM) ANOVA (for
comparing the results of behavioral tests) were per-
formed to examine the effects of the two factors, time
and treatment group, which was followed by the
Student-Newman-Keuls (SNK) Post hoc test. All data are
presented as mean ± SEM when applicable. p < 0.05 was
considered statistically significant.
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